ePRO (electronic Patient-Reported Outcome) is one of the four data types collected under eCOA (electronic Clinical Outcome Assessment): the one reported directly by the patient, with no clinician or observer in between. eCOA is the umbrella framework; ePRO, eClinRO, eObsRO and ePerfO are its four data sources. Every ePRO data point is an eCOA data point, but an eCOA program can run without ever using ePRO, if the protocol only calls for clinician-reported or performance-based assessments. The role of ePRO in a trial goes beyond questionnaires: reminders, time windows, compliance tracking.
Understanding how they interact helps clinical teams and sponsors design more robust protocols, improve data collection reliability, and deliver a smoother patient experience. In an industry where data quality directly impacts trial validity, making the right methodological choice during the study design phase is critical.
While these two tools share the same objective, they are not used in the same situations and do not address the same needs. ePRO is a component of eCOA, not its equivalent. Understanding this distinction is essential for sponsors looking to optimize patient monitoring and improve result reliability.
eCOA and ePRO: what do they actually mean?
eCOA (electronic Clinical Outcome Assessment) refers to the electronic collection of Clinical Outcome Assessments, meaning evaluations used to measure a participant’s health status, symptoms, functional abilities, or quality of life.
eCOA includes four types of assessments:
- ePRO: outcomes reported directly by the patient
- eClinRO: outcomes reported by a clinician
- eObsRO: outcomes reported by an observer such as a caregiver or parent
- ePerfO: outcomes based on performance tests completed by the patient
ePRO focuses specifically on information reported directly by the patient, without interpretation from a healthcare professional. It enables real time capture of information related to quality of life, symptoms, or patient experience throughout the study.
This makes ePRO particularly valuable because it gives patients a direct voice, something few clinical systems truly provide.
What are the main differences between eCOA and ePRO?
The fundamental difference lies in the source of the data. eCOA aggregates information coming from multiple stakeholders involved in the trial, including physicians, nurses, caregivers, and patients, while ePRO relies exclusively on patient-reported information. As a result, their role within a clinical protocol differs significantly.
| Criteria | eCOA | ePRO |
| Definition | Global framework for electronic clinical outcome collection | eCOA subcategory focused on patient reported data |
| Data source | Multiple : clinicians, caregivers, patients | Patient only |
| Measurement types | PRO ClinRO ObsRO PerfO | Symptoms, pain, fatigue, quality of life |
| Who completes it? | Depending on the assessment type: clinician, caregiver, or patient | Patient only |
| Typical use case | Complex multi stakeholder protocols | Studies focused on patient experience |
| Real time collection | ✓ Yes | ✓ Yes |
| Regulatory compliance | FDA 21 CFR Part 11 EU Annex 11 | FDA 21 CFR Part 11 EU Annex 11 |
In practice, how should you differentiate them?
- eCOA is used when the protocol involves multiple assessment sources including clinical teams, caregivers, and patients.
- ePRO is preferred when the study focuses on subjective patient experience such as pain, fatigue, well being, or treatment adherence.
- eCOA includes ePRO: every ePRO outcome is an eCOA outcome, but not every eCOA outcome is ePRO.
[[cta]]
BYOD vs provisioned devices: two deployment approaches
Most modern ePRO solutions rely on a BYOD (Bring Your Own Device) approach. Participants use their own smartphone, tablet, or computer to complete questionnaires.
This approach helps:
- reduce logistical costs
- accelerate international deployment
- avoid device distribution and maintenance
- provide a familiar experience for participants
In some studies, sponsors provide dedicated devices known as provisioned devices. This approach remains useful when the protocol requires a standardized technical environment or when participants do not have compatible equipment.
Today, BYOD is the most widely adopted strategy, especially in decentralized clinical trials.
What are the benefits for clinical research?
Adopting these electronic solutions in a clinical trial provides concrete benefits for sponsors, site teams, and patients alike.
Improved data reliability: electronic data capture reduces transcription errors and missing information commonly associated with paper-based processes.
Real-time data collection: data are timestamped and transmitted immediately, enabling real-time patient monitoring.
Better patient engagement: questionnaires accessible through mobile devices or tablets simplify participation, especially for patients located far from the clinical site.
Centralized data management for sponsors: data oversight becomes easier, with improved visibility into trial progress.
Examples of applications and best practices
In an oncology trial, an ePRO platform may be used to monitor fatigue or pain experienced by the patient between site visits. These patient reported data points, collected without intermediary interpretation, significantly enrich the clinical record.
At the same time, eClinRO, as part of the broader eCOA framework, allows investigators to document their own observations during each patient visit.
For successful implementation, several best practices should be followed:
- Clearly define in the protocol which outcome types are expected such as PRO, ClinRO, or ObsRO before selecting a solution.
- Train site teams on electronic interfaces to ensure consistent data collection.
- Provide patient support from study inclusion onward to maximize adherence to ePRO questionnaires.
- Ensure the selected solution complies with regulatory requirements including FDA 21 CFR Part 11 and EU Annex 11.
Solutions such as Datacapt natively integrate these capabilities to help teams maximize the value of their clinical data in real time while maintaining full regulatory compliance.
What is the difference between eCOA and ePRO?
eCOA (electronic Clinical Outcome Assessment) is the umbrella term for four types of electronically collected outcome data: PRO, ClinRO, ObsRO and PerfO. ePRO is the subset reported directly by the patient, without interpretation from a clinician.
Is ePRO a type of eCOA, or a separate system?
ePRO is one of the four data types inside eCOA, not a separate system. A platform that supports eCOA supports ePRO by definition; the reverse isn't true, since an eCOA program can run on clinician-reported or performance-based data alone.
When should a study use ePRO instead of broader eCOA?
When the protocol needs the patient's own account of symptoms, pain, fatigue or quality of life, without a clinician's interpretation between the patient and the data. Studies with multiple assessment sources (investigator, caregiver, patient) call for the broader eCOA framework instead.
Do ePRO and eCOA follow the same regulatory requirements?
Yes. Both fall under the same electronic records requirements, including FDA 21 CFR Part 11 and EU Annex 11, since both produce data used in regulatory submissions.
Can a study switch from paper PRO to ePRO mid-study?
Yes, on most modern platforms, as a configuration change rather than a rebuild, provided the new ePRO questionnaires map to the same patient record the eCRF already uses.
Florentin combines clinical research know-how with a true passion for product design. Attentive to detail and obsessed with user experience, he ensures that Datacapt remains a high-performance platform that’s also intuitive and accessible to every user.
Blog & News Datacapt
News, Articles, Resources et Tutorials.
